You may also like
Concentration of Circulating Microparticles: A New Biomarker of Acute Heart Failure after Cardiac Surgery with Cardiopulmonary Bypass
These data suggested that the concentration of circulating MPs might be a new biomarker for the occurrence of AHF after cardiac surgery with CPB.
Effect of the Neutrophil Elastase Inhibitor Sivelestat on Perioperative Inflammatory Response After Pediatric Heart Surgery with Cardiopulmonary Bypass: A Prospective Randomized Study
Cardiopulmonary bypass (CPB) elicits a systemic inflammatory response.
Long-term Outcome of Perioperative Low Cardiac Output Syndrome in Cardiac Surgery: 1-year Results of a Multicenter Randomized Trial
Levosimendan administration does not improve 1-year survival in cardiac surgery patients with perioperative myocardial dysfunction. One-year mortality in these patients is 17%. Six predictive factors for long-term mortality were identified.